People wearing protective face masks visit the lookout of Victoria Peak on February 25. Gilead Sciences plans to expand clinical studies of remdesivir, its antiviral drug for the treatment of Covid-19, in Hong Kong, South Korea, Taiwan and Singapore. Photo: Agence France-PressePeople wearing protective face masks visit the lookout of Victoria Peak on February 25. Gilead Sciences plans to expand clinical studies of remdesivir, its antiviral drug for the treatment of Covid-19, in Hong Kong, South Korea, Taiwan and Singapore. Photo: Agence France-Presse
People wearing protective face masks visit the lookout of Victoria Peak on February 25. Gilead Sciences plans to expand clinical studies of remdesivir, its antiviral drug for the treatment of Covid-19, in Hong Kong, South Korea, Taiwan and Singapore. Photo: Agence France-Presse

Coronavirus: Gilead to widen testing of antiviral drug in Hong Kong, South Korea, other Asian markets

  • The accelerated pace and scope of Gilead’s remdesivir clinical studies reflect the pressing need for Covid-19 treatment options

Topic |   Coronavirus South Korea
People wearing protective face masks visit the lookout of Victoria Peak on February 25. Gilead Sciences plans to expand clinical studies of remdesivir, its antiviral drug for the treatment of Covid-19, in Hong Kong, South Korea, Taiwan and Singapore. Photo: Agence France-PressePeople wearing protective face masks visit the lookout of Victoria Peak on February 25. Gilead Sciences plans to expand clinical studies of remdesivir, its antiviral drug for the treatment of Covid-19, in Hong Kong, South Korea, Taiwan and Singapore. Photo: Agence France-Presse
People wearing protective face masks visit the lookout of Victoria Peak on February 25. Gilead Sciences plans to expand clinical studies of remdesivir, its antiviral drug for the treatment of Covid-19, in Hong Kong, South Korea, Taiwan and Singapore. Photo: Agence France-Presse
READ FULL ARTICLE